Brown Financial Advisory’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$831K Sell
3,303
-419
-11% -$90.1K 0.35% 17
2026
Q1
$810K Buy
3,722
+9
+0.2% +$2K 0.4% 18
2025
Q4
$848K Hold
3,713
0.43% 17
2025
Q3
$860K Hold
3,713
0.45% 18
2025
Q2
$689K Buy
3,713
+662
+22% +$123K 0.38% 22
2025
Q1
$639K Buy
3,051
+1,131
+59% +$220K 0.4% 21
2024
Q4
$341K Buy
1,920
+155
+9% +$28.5K 0.24% 24
2024
Q3
$349K Hold
1,765
0.25% 22
2024
Q2
$303K Hold
1,765
0.23% 24
2024
Q1
$321K Sell
1,765
-39
-2% -$6.72K 0.25% 23
2023
Q4
$280K Hold
1,804
0.23% 24
2023
Q3
$269K Hold
1,804
0.24% 23
2023
Q2
$243K Hold
1,804
0.2% 27
2023
Q1
$288K Hold
1,804
0.28% 23
2022
Q4
$292K Hold
1,804
0.3% 22
2022
Q3
$242K Buy
+1,804
New +$259K 0.23% 25

Other funds holding ABBV

Brown Financial Advisory's ABBV Position: Q2 2026 in Review

Brown Financial Advisory reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $90.1K and leaving 3,303 shares worth $831K. The position accounts for 0.35% of the portfolio, ranked #17.

Brown Financial Advisory first reported a position in ABBV in Q3 2022 and has held it in 16 quarters since. The position peaked at $860K in Q3 2025. 2,094 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Brown Financial Advisory held 3,303 shares of AbbVie worth $831K as of Q2 2026.
  • Brown Financial Advisory sold 419 AbbVie shares in Q2 2026, an estimated $90.1K.
  • AbbVie made up 0.35% of Brown Financial Advisory's portfolio in Q2 2026, its #17 holding.
  • Brown Financial Advisory first reported a position in AbbVie in Q3 2022 and has held it in 16 quarters since.
  • Brown Financial Advisory's AbbVie position peaked at $860K in Q3 2025.
  • 2,094 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Brown Financial Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.